Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

8.50
-0.7700-8.31%
Post-market: 8.500.00000.00%19:05 EDT
Volume:134.19K
Turnover:1.15M
Market Cap:2.27B
PE:-9.82
High:8.88
Open:8.88
Low:8.40
Close:9.27
Loading ...

Alvotech SA expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
25 Mar

Icelandic Biotech Company Alvotech to Explore Listing in Stockholm

Dow Jones
·
20 Mar

Alvotech Expands with Acquisition of Xbrane’s R&D Operations

TIPRANKS
·
20 Mar

Alvotech to Acquire Xbrane Biopharma's R&D Operations, Biosimilar Candidate

MT Newswires Live
·
20 Mar

Alvotech Sa - Acquisition Valued at Approximately SEK 275 Million (USD 27 Million)

THOMSON REUTERS
·
20 Mar

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms Its Global Leadership Position in Biosimilars Development and Production

THOMSON REUTERS
·
20 Mar

Alvotech Sa - to Explore Listing of Swedish Depository Receipts on Nasdaq Stockholm

THOMSON REUTERS
·
20 Mar

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

GlobeNewswire
·
20 Mar

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Zacks
·
19 Mar

BRIEF-Alvotech, Dr. Reddy's Announce FDA Acceptance Of Biologic License Application

Reuters
·
18 Mar

Dr. Reddy's, Alvotech Say FDA Accepts Biologic License Application for Bone Drug Biosimilar

MT Newswires Live
·
18 Mar

Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03

TIPRANKS
·
18 Mar

Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

GlobeNewswire
·
18 Mar

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

GlobeNewswire
·
07 Mar

J&J sues Samsung Bioepis over contract breach for Stelara biosimilar

Reuters
·
25 Feb

Alvotech Launches SELARSDI Biosimilar in U.S. Market

TIPRANKS
·
24 Feb

Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET

GlobeNewswire
·
24 Feb

BUZZ-Alvotech rallies after US biosimilar launch

Reuters
·
22 Feb

Alvotech Sa Shares Rise 5.6% After Co and Teva Pharma Launch Biosimilar to J&J's Stelara in US

THOMSON REUTERS
·
22 Feb

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Friday Amid Ongoing Tariff Uncertainties

MT Newswires Live
·
21 Feb